Sterling Pharma Solutions Acquires Alcami's Germantown (WI) API Facility

GHO Capital Acquires Majority Stake in Sterling Pharma Solutions

February 28, 2019

Pharmaceuticals

GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.

GHO Capital and The Vistria Group Acquire Alcami Corporation

January 3, 2023

Healthcare Services

GHO Capital Partners and The Vistria Group have acquired a 50/50 controlling interest in Alcami Corporation from funds affiliated with Madison Dearborn Partners and Ampersand Capital Partners. Alcami is a US-based contract development and manufacturing organization (CDMO) with capabilities in sterile fill-finish, formulation and analytical lab services, and cGMP biostorage; Ampersand and Alcami management reinvested significant equity as part of the transaction.

Alcami Corporation Acquires Pacific Pharmaceutical Services

January 17, 2024

Healthcare Services

Alcami Corporation has completed the acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a Reno-based cGMP pharmaceutical storage and clinical-support provider. The deal expands Alcami’s pharma storage and services footprint to the U.S. West Coast, enabling bicoastal coverage and enhanced support for pre-clinical and early clinical trial material management.

Alcami Acquires TriPharm Services to Expand Sterile Fill‑Finish Capacity

January 17, 2020

Pharmaceuticals

Alcami Corporation has acquired TriPharm Services, a new sterile fill‑finish manufacturing center near Research Triangle Park, North Carolina. Funds affiliated with Alcami majority owner Madison Dearborn Partners made an additional equity investment to support Alcami's growth plan, while Ampersand Capital Partners rolled a portion of its TriPharm ownership into Alcami.

Sterling Pharma Solutions Acquires Novartis Ringaskiddy API Manufacturing Facility

January 11, 2023

Pharmaceuticals

Sterling Pharma Solutions, a GHO Capital portfolio company, has completed the acquisition of the Novartis API manufacturing facility in Ringaskiddy, County Cork, Ireland. The 111-acre site (with ~350 transferred employees and extensive commercial-scale API production capacity) expands Sterling's European manufacturing footprint and includes an ongoing supply agreement with Novartis.

GHO Capital and Partners Group Invest in Sterling Pharma Solutions

May 25, 2023

Pharmaceuticals

GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.